News & Press: Advocacy

IPSIS Urges California and New Jersey Plans to Cover Third Occipital Nerve RF

Friday, January 11, 2019  
On January 7, 2019, IPSIS presented evidence to Blue Shield of California and Horizon Blue Cross Blue Shield of New Jersey in support of coverage for radiofrequency denervation of the third occipital nerve (C2-3), providing a detailed summary of the evidence of effectiveness in appropriately selected patients.